Generative AI for graph-based drug design: Recent advances and the way forward

Area of Science:

• Drug discovery and development
• Computational chemistry
• Artificial intelligence in medicine

Background:

• Drug discovery is a complex process challenged by the immense size of the molecular search space.
• Identifying promising drug candidates requires innovative computational approaches.
• Artificial intelligence (AI) presents a potential solution to streamline the drug design pipeline.

Purpose of the Study:

• To review the current state-of-the-art in AI-driven generative models for molecular graph representation.
• To identify limitations in existing AI methodologies for drug design.
• To outline future research directions for leveraging AI in discovering novel drug candidates.

Main Methods:

• Review of recent advancements in generative models applied to molecular graphs.
• Analysis of methodologies for learning from molecular data structures.
• Exploration of AI techniques for navigating discrete and vast chemical spaces.

Main Results:

• Generative models operating on molecular graphs show significant promise for drug design.
• Current methodologies face limitations in effectively exploring the full molecular search space.
• AI offers a pathway to overcome traditional challenges in identifying novel therapeutic molecules.

Conclusions:

• AI-powered generative models are crucial for advancing drug discovery.
• Further research is needed to address the limitations of current AI approaches.
• Harnessing AI's potential can significantly accelerate the identification of effective drug candidates.